ZA851765B - Anti-viral pharmaceutical preparations and methods for their use - Google Patents

Anti-viral pharmaceutical preparations and methods for their use

Info

Publication number
ZA851765B
ZA851765B ZA851765A ZA851765A ZA851765B ZA 851765 B ZA851765 B ZA 851765B ZA 851765 A ZA851765 A ZA 851765A ZA 851765 A ZA851765 A ZA 851765A ZA 851765 B ZA851765 B ZA 851765B
Authority
ZA
South Africa
Prior art keywords
methods
pharmaceutical preparations
viral pharmaceutical
viral
lidocaine
Prior art date
Application number
ZA851765A
Other languages
English (en)
Inventor
Harold Gray Haines
Caroline Burgess Dickens
Original Assignee
Brigham Dana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham Dana filed Critical Brigham Dana
Publication of ZA851765B publication Critical patent/ZA851765B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA851765A 1984-03-08 1985-03-08 Anti-viral pharmaceutical preparations and methods for their use ZA851765B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/587,398 US4628063A (en) 1984-03-08 1984-03-08 Antiviral pharmaceutical preparations and methods for their use

Publications (1)

Publication Number Publication Date
ZA851765B true ZA851765B (en) 1985-11-27

Family

ID=24349633

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA851765A ZA851765B (en) 1984-03-08 1985-03-08 Anti-viral pharmaceutical preparations and methods for their use

Country Status (13)

Country Link
US (2) US4628063A (de)
EP (1) EP0154344B1 (de)
JP (1) JPH0676317B2 (de)
AT (1) ATE91233T1 (de)
AU (1) AU571072B2 (de)
DE (1) DE3587434T2 (de)
ES (1) ES8700053A1 (de)
IE (1) IE61525B1 (de)
IL (1) IL74535A (de)
NZ (1) NZ211361A (de)
PT (1) PT80079B (de)
WO (1) WO1985003862A1 (de)
ZA (1) ZA851765B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
US5284664A (en) * 1988-08-04 1994-02-08 Kremers-Urban Company Method of treating the symptoms of Alzheimer's disease
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
US5316775A (en) * 1988-08-04 1994-05-31 Kremers-Urban Company Method of treating hepatitis B infection
US5334395A (en) * 1988-08-04 1994-08-02 Kremers-Urban Company Method of treating an epstein-barr viral infection
SE8804214L (sv) * 1988-11-22 1990-05-23 Jean Cassuto Antiinflammatoriskt och antiinfektioest medikament
US4997853A (en) * 1988-12-02 1991-03-05 Galenpharma, Inc. Method and compositions utilizing capsaicin as an external analgesic
US5331012A (en) * 1990-07-30 1994-07-19 Riddick Kenneth B Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
GB9027433D0 (en) * 1990-12-18 1991-02-06 Merrell Dow Pharma Anti-herpes castanospermine esters
JP3115625B2 (ja) * 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
HU212426B (en) * 1992-07-22 1996-06-28 Vepex Kft Process for producing bioactive pharmaceutical compositions
EP0643964A3 (de) * 1993-08-18 1995-08-09 Medipharma Sa Verwendung von Lokalanästhetika zur Herstellung eines Arzneimittels zum Schutz der Membran von Plasmazellen.
CA2130291A1 (en) * 1993-08-18 1995-02-19 Juan Carlos Mahiques Therapeutic uses of known ester and amide compounds
US5506236A (en) * 1994-04-28 1996-04-09 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US5776859A (en) * 1995-11-15 1998-07-07 Nickel; Alfred A. Sodium channel active novel compounds and related processes and bioassay techniques
US5869446A (en) * 1996-07-09 1999-02-09 Gambit International Limited Preparation of lactoferrin (or serotransferrin or ovotransferrin) and desferrioxamine methanesulfonate (or other low molecular weight metal ion chelators) for the therapy of viral infections
DE19823319A1 (de) * 1998-05-26 1999-12-02 Karl Engelhard, Fabrik Pharm.- Praeparate Gmbh & Co. Kg Topisch anwendbares Arzneimittel zur Behandlung von Virusinfektionen
US6093417A (en) * 1999-01-11 2000-07-25 Advanced Medical Instruments Composition to treat ear disorders
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
WO2007039825A2 (en) 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
ITRM20060163A1 (it) * 2006-03-24 2007-09-25 Ist Farmacoterapico It Spa Composizione spray ad uso topico per il tratamento e la prevenzione delle infezioni labiali da herpes simplex
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
EP2242476A2 (de) 2008-01-14 2010-10-27 Foamix Ltd. Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
IT201800007009A1 (it) * 2018-07-06 2020-01-06 Nuovo uso medico di anestetici locali

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1315727A (fr) * 1961-06-13 1963-01-25 Perfectionnement aux véhicules-jouets
FR2484257A1 (fr) * 1980-06-16 1981-12-18 Girard Michele Composition polyvitaminee pour le traitement de l'herpes

Also Published As

Publication number Publication date
US4757088A (en) 1988-07-12
NZ211361A (en) 1988-07-28
AU4067385A (en) 1985-09-24
ES8700053A1 (es) 1986-10-16
EP0154344A2 (de) 1985-09-11
ES541103A0 (es) 1986-10-16
WO1985003862A1 (en) 1985-09-12
JPS61501325A (ja) 1986-07-03
IL74535A (en) 1988-12-30
ATE91233T1 (de) 1993-07-15
IE850581L (en) 1985-09-08
JPH0676317B2 (ja) 1994-09-28
PT80079B (pt) 1987-09-18
DE3587434T2 (de) 1994-02-17
EP0154344B1 (de) 1993-07-07
DE3587434D1 (de) 1993-08-12
US4628063A (en) 1986-12-09
PT80079A (en) 1985-04-01
IE61525B1 (en) 1994-11-16
EP0154344A3 (en) 1990-06-13
AU571072B2 (en) 1988-03-31
IL74535A0 (en) 1985-06-30

Similar Documents

Publication Publication Date Title
ZA851765B (en) Anti-viral pharmaceutical preparations and methods for their use
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
PT80157A (en) Methods of treating viral diseases with pyridazinamines anti-virally active pyridazinamines
IL76777A (en) Inositoltriphosphates,their preparation and pharmaceutical compositions containing them
PL269462A1 (en) Method for manufacturing 5-substituted pyrimydine nucleosides
EP0270317A3 (de) Pharmaceutische Zuberatung zur Behandlung von Virus-Krankheiten
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
DK326586A (da) Antivirale pyrimidinforbindelser, farmaceutiske kompositioner indeholdende forbindelserne og kompositionernes fremstilling
DE3473272D1 (en) Guanine derivatives, compositions containing them, and their anti-viral use
DE3685484D1 (de)
EP0284405A3 (de) Antivirale Verbindungen, Dosiereinheiten und Verfahren
FI853228A7 (fi) Uudet -butyrolaktaamit, niiden farmaseuttisesti aktiiviset koostumukset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkeaineina.
AU8447991A (en) Antineoplastic effect potentiator and antineoplastic agent
EP0080032A3 (de) Pharmazeutische Zubereitung für die Behandlung von herpetischen Verletzungen
HUP9900945A2 (hu) Nukleozidanalógok herpes simplex vírus fertőzések kombinációs terápiájában
CA2255856A1 (en) Therapeutic uses for an aminosterol compound
CA2082270A1 (en) Anti-viral therapy
SE8802193D0 (sv) Externally applicable, antiviral pharmaceutical composition accumulating in the skin and process for the preparation of the same
IL107818A (en) Pharmaceutical compositions for treating viral infections by conjunctive therapy with acylovir-like compounds and a 2'-(halo) methylene nucleoside analog
ES8303297A1 (es) Un procedimiento para la preparacion de un nuevo reptido activo.
AU1575688A (en) Medicinal composition for treating and preventing diseases caused by cytotoxicity by cellular mediation, incorporating at least one pyridine derivate as active principle
GB2125700A (en) Anti-viral treatment method
MY101495A (en) Treatment of diseases caused by viruses
UA26326C2 (uk) Спосіб лікуваhhя захворюваhь вірусhої та бактеріальhої етіології у людиhи і твариhи та композиція для його реалізації